---
title: "agilon health, inc. Stock 12‑Month Price Target Raised to $27.14, Implies 3% Downside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285561456.md"
description: "Agilon Health, Inc.'s 12-month stock price target has been raised to $27.14, indicating a potential downside of 3%. Analysts' average price target increased from $20.73 to $25.93, with estimates ranging from $6.25 to $49 per share. The consensus rating remains a 'Hold' from 17 analysts, comprising 4 Buys, 10 Holds, and 3 Sells. This information is based on the latest analyst recommendations and does not constitute investment advice."
datetime: "2026-05-07T13:20:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285561456.md)
  - [en](https://longbridge.com/en/news/285561456.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285561456.md)
---

# agilon health, inc. Stock 12‑Month Price Target Raised to $27.14, Implies 3% Downside

-   According to estimates from 13 analysts, agilon health, inc. stock's average price target has risen from $20.73 to $25.93, with forecasts ranging from $6.25 to $49 per share
-   Based on the May 6 closing price, the updated target implies approximately 7% potential downside
-   Consensus rating remains at “Hold” across 17 covering analysts, with 4 Buys, 10 Holds and 3 Sells

Explore more price target data and ratings for agilon health, inc. on the , and track all previous and future analyst recommendations for agilon health, inc. in the dedicated News Flow

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [AGL.US](https://longbridge.com/en/quote/AGL.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Did agilon health, inc. Insiders Breach their Fiduciary Duties to Shareholders? | AGL Stock News](https://longbridge.com/en/news/282261952.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Earnings Beat: Deepak Nitrite Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286980047.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [Earnings Beat: Odfjell Drilling Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286515920.md)